INTELLIGENT BIO SOLUTIONS INC. — Form 10-K
Filed August 19, 2026 · analyzed by the Periodic Agent
10-K
▼ Likely negative
significance 72/100
What the filing says
The filing presents standard boilerplate describing INBS's common stock (100M authorized shares at $0.01 par, one vote per share, no cumulative voting) listed on Nasdaq Capital Market under symbol INBS, plus three subsidiaries (98.96% ownership of Australian APAC entity, 100% of Delaware GBS Operations, 100% of UK Intelligent Fingerprinting). Critically, the independent auditor (UHY LLP) flagged in their August 19, 2026 report an 'explanatory paragraph regarding the Company's ability to continue as a going concern'—a red flag indicating material doubt about the company's viability.
Why this rating
Going-concern warning is severe for a $6.6M market-cap microcap and signals existential risk; boilerplate securities description is routine, but the audit qualification dominates materiality.
See more from August 19, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.